157 related articles for article (PubMed ID: 16974209)
1. High-dose quetiapine and photopsia.
Hazra M; Culo S; Mamo D
J Clin Psychopharmacol; 2006 Oct; 26(5):546-7. PubMed ID: 16974209
[No Abstract] [Full Text] [Related]
2. Dose-dependent constipation with higher doses of quetiapine: a case series.
Raedler TJ; Reimer J; Wiedemann K
Int Clin Psychopharmacol; 2007 Jul; 22(4):244-6. PubMed ID: 17519649
[TBL] [Abstract][Full Text] [Related]
3. Seizures associated with quetiapine treatment.
Dogu O; Sevim S; Kaleagasi HS
Ann Pharmacother; 2003 Sep; 37(9):1224-7. PubMed ID: 12921503
[TBL] [Abstract][Full Text] [Related]
4. New-onset diabetes mellitus associated with quetiapine.
Procyshyn RM; Pande S; Tse G
Can J Psychiatry; 2000 Sep; 45(7):668-9. PubMed ID: 11056833
[No Abstract] [Full Text] [Related]
5. Dosing quetiapine in drug-naive first-episode psychosis: a controlled, double-blind, randomized, single-center study investigating efficacy, tolerability, and safety of 200 mg/day vs. 400 mg/day of quetiapine fumarate in 141 patients aged 15 to 25 years.
Berger GE; Proffitt TM; McConchie M; Kerr M; Markulev C; Yuen HP; O'Donnell C; Lubman D; Polari A; Wood S; Amminger PG; McGorry PD
J Clin Psychiatry; 2008 Nov; 69(11):1702-14. PubMed ID: 19036233
[TBL] [Abstract][Full Text] [Related]
6. Patterns of quetiapine use in psychiatric inpatients: an examination of off-label use.
Philip NS; Mello K; Carpenter LL; Tyrka AR; Price LH
Ann Clin Psychiatry; 2008; 20(1):15-20. PubMed ID: 18297582
[TBL] [Abstract][Full Text] [Related]
7. Quetiapine: efficacy, tolerability and safety in schizophrenia.
Miodownik C; Lerner V
Expert Rev Neurother; 2006 Jul; 6(7):983-92. PubMed ID: 16831113
[TBL] [Abstract][Full Text] [Related]
8. Urinary retention following repeated high-dose quetiapine.
Sokolski KN; Brown BJ; Melden M
Ann Pharmacother; 2004 May; 38(5):899-900. PubMed ID: 15039480
[No Abstract] [Full Text] [Related]
9. Quetiapine not quiet-a-pine--not a sleeper.
Zarowitz BJ
Geriatr Nurs; 2011; 32(1):46-8. PubMed ID: 21295716
[No Abstract] [Full Text] [Related]
10. Quetiapine-induced hypothyroidism.
Ramaswamy S; Siddiqui Z; Saharan S; Gabel TL; Bhatia SC
J Psychiatry Neurosci; 2005 Jan; 30(1):57. PubMed ID: 15645000
[No Abstract] [Full Text] [Related]
11. Quetiapine-related dysphagia.
Armstrong D; Ahuja N; Lloyd AJ
Psychosomatics; 2008; 49(5):450-2. PubMed ID: 18794516
[No Abstract] [Full Text] [Related]
12. Neuroleptic malignant syndrome associated with quetiapine.
al-Waneen R
Can J Psychiatry; 2000 Oct; 45(8):764-5. PubMed ID: 11086565
[No Abstract] [Full Text] [Related]
13. [Abuse of quetiapine. Two addicted patients with borderline personality disorder].
Galyuk TM; de Backer G; de Jong CA; Beers E; Loonen AJ
Ned Tijdschr Geneeskd; 2009 Apr; 153(14):674-6. PubMed ID: 19425328
[No Abstract] [Full Text] [Related]
14. Quetiapine-induced peripheral edema.
Roy K; Astreika V; Dunn JE; Sappati Biyyani RS
Gen Hosp Psychiatry; 2009; 31(2):194-5. PubMed ID: 19269545
[TBL] [Abstract][Full Text] [Related]
15. Neuroleptic malignant syndrome with use of quetiapine in mental retardation.
Dan A; Bharadwaj R; Grover S
Psychiatry Clin Neurosci; 2009 Apr; 63(2):255-6. PubMed ID: 19335404
[No Abstract] [Full Text] [Related]
16. Comment on: low-dose quetiapine-induced severe rhabdomyolysis.
Ceri M; Unverdi S; Altay M; Duranay M
Ren Fail; 2011; 33(4):463-4. PubMed ID: 21529278
[No Abstract] [Full Text] [Related]
17. Quetiapine in the treatment of acute mania: target dose for efficacious treatment.
Vieta E; Goldberg JF; Mullen J; Vågerö M; Paulsson B
J Affect Disord; 2007; 100 Suppl 1():S23-31. PubMed ID: 17382403
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic drug monitoring of quetiapine in adolescents with psychotic disorders.
Gerlach M; Hünnerkopf R; Rothenhöfer S; Libal G; Burger R; Clement HW; Fegert JM; Wewetzer Ch; Mehler-Wex C
Pharmacopsychiatry; 2007 Mar; 40(2):72-6. PubMed ID: 17447177
[TBL] [Abstract][Full Text] [Related]
19. Quetiapine in the treatment of psychotic adolescents: a case series of 23 patients with severe early onset psychosis.
Beer F; Heinrich H; Springer S; Rüth U; Freisleder FJ
World J Biol Psychiatry; 2007; 8(1):38-41. PubMed ID: 17366348
[TBL] [Abstract][Full Text] [Related]
20. Rapid dose initiation of quetiapine for the treatment of acute schizophrenia and schizoaffective disorder: a randomised, multicentre, parallel-group, open study.
Boidi G; Ferro M
Hum Psychopharmacol; 2007 Jul; 22(5):299-306. PubMed ID: 17487936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
